Acute Lymphocytic Leukaemia Refractory
1 clinical trials · Condition
◉ Watch Acute Lymphocytic Leukaemia Refractory
| Record | Firm | Date |
|---|---|---|
| CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies (NCT04603872) | Zhejiang University | 2020-11-01 |
Track Acute Lymphocytic Leukaemia Refractory automatically
Every clearance here is in the API, with alerts when new ones post.